SOPHNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
SOPHiA GENETICS SA
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 3, 2026
$6.49−0.24 (-3.57%)
Close on Oct 19, 2026
- Market cap
- $479.21M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$2.18 (+50.58%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
SOPHiA GENETICS SA grew revenue 18.6% to $77.27M over fiscal 2025. Free cash flow was -$36.47M.
Revenue
$77.27M
+18.6% vs. a year earlier
Operating income
-$70.91M
FY2025
Free cash flow
-$36.47M
FY2025
EPS, diluted
-$1.17
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $479.21M
- P/E ratio
- –
- Price to sales
- 6.20
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -7.61%
Fundamentals
- Revenue
- $77.27M
- Net income
- -$79.00M
- EPS, diluted
- -$1.17
- Free cash flow
- -$36.47M
- Diluted shares
- 74M
Eight years at a glance
Fiscal years 2018 to 2025, USD
Revenue
$77.27M+18.6% YoY
Gross profit
$52.08M+18.5% YoY
Operating income
-$70.91M
Net income
-$79.00M
EPS, diluted
-$1.17
Free cash flow
-$36.47M
Reported period